Header Logo

Connection

JIN WANG to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications JIN WANG has written about Drug Resistance, Neoplasm.
JIN WANG
Connection Strength
0.124
Drug Resistance, Neoplasm
  1. Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nat Commun. 2021 02 15; 12(1):1022.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.